Health & Personal Care
HIGH
FDA DRUG
ENTECAVIR Entecavir 0.5 mg Tablets Recalled Nationwide Over Impurity (2025)
Ent ecavir 0.5 mg tablets, distributed nationwide in the United States by Zydus Pharmaceuticals USA Inc., are recalled, affecting 912 bottles. The recall is due to an out-of-specification organic impurity detected in a batch, Class II. Healthcare providers and patients should stop using the product immediately and contact Zydus Pharmaceuticals USA for guidance.
ENTECAVIR
Failed impurity/degradation